Improvement of patient tolerance to dapsone: current and future developments.
Coleman
Michael D
MD
D000975:Antioxidants / Q000627:therapeutic use*; D002927:Cimetidine / Q000627:therapeutic use; D003622:Dapsone / Q000009:adverse effects*; D003879:Dermatologic Agents / Q000009:adverse effects*; D064420:Drug-Related Side Effects and Adverse Reactions / Q000517:prevention & control*; D006801:Humans; D008063:Thioctic Acid / Q000627:therapeutic use
D000975:Antioxidants; D003879:Dermatologic Agents; D008063:Thioctic Acid; D002927:Cimetidine; D003622:Dapsone